Annual D&A
$18.28 M
+$4.52 M+32.88%
December 31, 2023
Summary
- As of February 12, 2025, FATE annual depreciation & amortization is $18.28 million, with the most recent change of +$4.52 million (+32.88%) on December 31, 2023.
- During the last 3 years, FATE annual D&A has risen by +$15.20 million (+492.23%).
- FATE annual D&A is now at all-time high.
Performance
FATE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$4.61 M
-$114.00 K-2.41%
September 30, 2024
Summary
- As of February 12, 2025, FATE quarterly depreciation & amortization is $4.61 million, with the most recent change of -$114.00 thousand (-2.41%) on September 30, 2024.
- Over the past year, FATE quarterly D&A has dropped by -$133.00 thousand (-2.81%).
- FATE quarterly D&A is now -5.69% below its all-time high of $4.88 million, reached on December 31, 2023.
Performance
FATE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$19.03 M
-$133.00 K-0.69%
September 30, 2024
Summary
- As of February 12, 2025, FATE TTM depreciation & amortization is $19.03 million, with the most recent change of -$133.00 thousand (-0.69%) on September 30, 2024.
- Over the past year, FATE TTM D&A has increased by +$795.00 thousand (+4.36%).
- FATE TTM D&A is now -0.69% below its all-time high of $19.17 million, reached on June 30, 2024.
Performance
FATE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
FATE Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.9% | -2.8% | +4.4% |
| 3 y3 years | +492.2% | +9.9% | +25.3% |
| 5 y5 years | +1418.4% | +553.5% | +674.4% |
FATE Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +212.5% | -5.7% | +108.8% | -0.7% | +225.4% |
| 5 y | 5-year | at high | +733.6% | -5.7% | +639.5% | -0.7% | +767.9% |
| alltime | all time | at high | +3585.9% | -5.7% | +3906.1% | -0.7% | >+9999.0% |
Fate Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.61 M(-2.4%) | $19.03 M(-0.7%) |
| Jun 2024 | - | $4.72 M(-2.1%) | $19.17 M(+1.3%) |
| Mar 2024 | - | $4.82 M(-1.3%) | $18.91 M(+3.4%) |
| Dec 2023 | $18.28 M(+32.9%) | $4.88 M(+3.1%) | $18.28 M(+0.2%) |
| Sep 2023 | - | $4.74 M(+6.1%) | $18.24 M(+9.3%) |
| Jun 2023 | - | $4.47 M(+6.6%) | $16.69 M(+9.9%) |
| Mar 2023 | - | $4.19 M(-13.4%) | $15.19 M(+10.4%) |
| Dec 2022 | $13.76 M(+135.2%) | $4.84 M(+51.6%) | $13.76 M(+23.7%) |
| Sep 2022 | - | $3.19 M(+7.8%) | $11.12 M(+17.7%) |
| Jun 2022 | - | $2.96 M(+7.3%) | $9.45 M(+23.5%) |
| Mar 2022 | - | $2.76 M(+25.2%) | $7.65 M(+30.8%) |
| Dec 2021 | $5.85 M(+89.5%) | $2.21 M(+45.2%) | $5.85 M(+29.9%) |
| Sep 2021 | - | $1.52 M(+30.3%) | $4.50 M(+19.8%) |
| Jun 2021 | - | $1.17 M(+21.6%) | $3.76 M(+12.5%) |
| Mar 2021 | - | $959.00 K(+11.4%) | $3.34 M(+8.2%) |
| Dec 2020 | $3.09 M(+40.8%) | $861.00 K(+11.4%) | $3.09 M(+8.4%) |
| Sep 2020 | - | $773.00 K(+3.3%) | $2.85 M(+7.0%) |
| Jun 2020 | - | $748.00 K(+6.1%) | $2.66 M(+8.3%) |
| Mar 2020 | - | $705.00 K(+13.2%) | $2.46 M(+12.1%) |
| Dec 2019 | $2.19 M(+82.1%) | $623.00 K(+6.1%) | $2.19 M(+15.6%) |
| Sep 2019 | - | $587.00 K(+8.1%) | $1.90 M(+17.1%) |
| Jun 2019 | - | $543.00 K(+23.4%) | $1.62 M(+19.3%) |
| Mar 2019 | - | $440.00 K(+34.6%) | $1.36 M(+12.8%) |
| Dec 2018 | $1.20 M | $327.00 K(+5.5%) | $1.20 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $310.00 K(+10.3%) | $1.17 M(+6.0%) |
| Jun 2018 | - | $281.00 K(-1.7%) | $1.10 M(+4.8%) |
| Mar 2018 | - | $286.00 K(-1.4%) | $1.05 M(+8.2%) |
| Dec 2017 | $971.00 K(+10.2%) | $290.00 K(+18.9%) | $971.00 K(+9.8%) |
| Sep 2017 | - | $244.00 K(+5.6%) | $884.00 K(+3.0%) |
| Jun 2017 | - | $231.00 K(+12.1%) | $858.00 K(-0.2%) |
| Mar 2017 | - | $206.00 K(+1.5%) | $860.00 K(-2.4%) |
| Dec 2016 | $881.00 K(+28.2%) | $203.00 K(-6.9%) | $881.00 K(-0.8%) |
| Sep 2016 | - | $218.00 K(-6.4%) | $888.00 K(+3.6%) |
| Jun 2016 | - | $233.00 K(+2.6%) | $857.00 K(+9.0%) |
| Mar 2016 | - | $227.00 K(+8.1%) | $786.00 K(+14.4%) |
| Dec 2015 | $687.00 K(+38.5%) | $210.00 K(+12.3%) | $687.00 K(+14.1%) |
| Sep 2015 | - | $187.00 K(+15.4%) | $602.00 K(+13.6%) |
| Jun 2015 | - | $162.00 K(+26.6%) | $530.00 K(+5.8%) |
| Mar 2015 | - | $128.00 K(+2.4%) | $501.00 K(+1.0%) |
| Dec 2014 | $496.00 K(-13.1%) | $125.00 K(+8.7%) | $496.00 K(-0.8%) |
| Sep 2014 | - | $115.00 K(-13.5%) | $500.00 K(-4.8%) |
| Jun 2014 | - | $133.00 K(+8.1%) | $525.00 K(-2.2%) |
| Mar 2014 | - | $123.00 K(-4.7%) | $537.00 K(-6.0%) |
| Dec 2013 | $571.00 K(-3.2%) | $129.00 K(-7.9%) | $571.00 K(+29.2%) |
| Sep 2013 | - | $140.00 K(-3.4%) | $442.00 K(+46.4%) |
| Jun 2013 | - | $145.00 K(-7.6%) | $302.00 K(+92.4%) |
| Mar 2013 | - | $157.00 K | $157.00 K |
| Dec 2012 | $590.00 K(-12.2%) | - | - |
| Dec 2011 | $672.00 K | - | - |
FAQ
- What is Fate Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Fate Therapeutics?
- What is Fate Therapeutics annual D&A year-on-year change?
- What is Fate Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Fate Therapeutics?
- What is Fate Therapeutics quarterly D&A year-on-year change?
- What is Fate Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Fate Therapeutics?
- What is Fate Therapeutics TTM D&A year-on-year change?
What is Fate Therapeutics annual depreciation & amortization?
The current annual D&A of FATE is $18.28 M
What is the all time high annual D&A for Fate Therapeutics?
Fate Therapeutics all-time high annual depreciation & amortization is $18.28 M
What is Fate Therapeutics annual D&A year-on-year change?
Over the past year, FATE annual depreciation & amortization has changed by +$4.52 M (+32.88%)
What is Fate Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of FATE is $4.61 M
What is the all time high quarterly D&A for Fate Therapeutics?
Fate Therapeutics all-time high quarterly depreciation & amortization is $4.88 M
What is Fate Therapeutics quarterly D&A year-on-year change?
Over the past year, FATE quarterly depreciation & amortization has changed by -$133.00 K (-2.81%)
What is Fate Therapeutics TTM depreciation & amortization?
The current TTM D&A of FATE is $19.03 M
What is the all time high TTM D&A for Fate Therapeutics?
Fate Therapeutics all-time high TTM depreciation & amortization is $19.17 M
What is Fate Therapeutics TTM D&A year-on-year change?
Over the past year, FATE TTM depreciation & amortization has changed by +$795.00 K (+4.36%)